Breaking News

Cuts, ousters and drama at the FDA

April 4, 2025

Turmoil, job cuts and forced ousters of high-ranking officials at federal health agencies. Marty Makary's rough first week as FDA Commissioner. Biotech stocks tumble even further. President Trump's "Liberation Day" tariffs roil global markets. 

We talk about biotech's volatile week with STAT's FDA reporter Lizzy Lawrence and interview AstraZeneca R&D executive Sharon Barr on this week's episode of the "The Readout LOUD."  

Listen Now

For more on Lizzy's FDA reporting, click here. Adam's takes on how the FDA turmoil is roiling the biotech industry and stock prices can be found here. STAT's ongoing coverage of the Trump administration's impact on health agencies can be found here.

Subscribe to the podcast on Apple Podcasts or Spotify to never miss an episode

Visit the archive to see past episodes 



Enjoying The Readout LOUD? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2025, All Rights Reserved.

No comments